JP6224381B2 - Drug container - Google Patents

Description

  The present invention relates to a drug body container that contains a drug body having a shape-retaining property while containing a drug such as a fragrance, a deodorant, and a deodorant.

  2. Description of the Related Art Conventionally, a drug body container that contains a drug body that contains a drug such as a fragrance and has shape retention properties is known. For example, Patent Document 1 discloses a drug body container including a refill main body that supports a drug body having shape retention, and a refill lid that houses the drug body together with the refill main body. The refill main body includes a deep dish portion that holds a lower portion of the drug body, and a concave rib that is connected to an upper end of the deep dish portion and engages the refill lid body. The refill lid is a cylindrical portion, a canopy that closes the upper opening of the cylindrical portion, and an inverted L-shape that is provided on the outer peripheral surface of the lower end portion of the cylindrical portion and can be engaged with the concave rib. And ribs. The inverted L-shaped rib is engaged with the concave rib by rotating the cylindrical portion with respect to the refill body in an engagement direction which is one side in the circumferential direction, while the cylindrical portion is in the engagement direction. It is detached from the concave rib by rotating in the release direction opposite to the above.

  Usually, the said drug substance container distribute | circulates the state which accommodated the said drug substance in the inside. When exposing the medicine body accommodated in the medicine body container, first, the refill lid body is rotated relative to the refill body in the circumferential release direction. As a result, the engagement between the inverted L-shaped rib and the concave rib is released. And the said refill lid body is removed from the refill body by displacing the refill lid body in the direction away from the refill body in the axial direction. As a result, the drug body held in the deep dish portion is exposed.

Japanese Utility Model Publication No. 06-28105

  In the drug body container described in Patent Document 1, when the refill lid body (hereinafter referred to as “cover member”) is removed from the refill body, the cover member is bent and deformed, whereby a compressive force acts on the drug body. There is a case. Specifically, since the lower end portion of the cylindrical portion of the cover member is a free end and the strength is relatively low in the cylindrical portion, the cylindrical portion is gripped and attached to the refill body. When the cover member is displaced in a direction away from the refilling body in the axial direction after releasing the engagement of the concave rib and the inverted L-shaped rib by rotating in the release direction of the direction. In addition, the lower end portion of the cylindrical portion, which is a free end in particular, is deflected inward by a force for gripping the cylindrical portion, and thus a compressive force may act on the drug body. In this case, there is a possibility that the drug solution may be squeezed out from the drug body.

  The objective of this invention is providing the chemical | medical agent container which can suppress the deformation | transformation of the said cover member at the time of removal of a cover member.

  In order to solve the above-mentioned problem, it is conceivable to provide a reinforcing rib on the outer peripheral surface of the lower end portion which is the free end of the cover member covering the drug body. However, since a locked portion that is locked to a support member that supports the drug body is provided on the outer peripheral surface of the lower end portion of the cover member, a reinforcing rib is provided on the outer peripheral surface of the lower end portion of the cover member. It is difficult to secure the space.

  Therefore, the present inventor does not separately provide a dedicated reinforcing portion for reinforcing the cover member, but uses a locked portion provided in the cover member for engagement between the cover member and the support member. Thus, it has been conceived that the rigidity of the cover member is ensured by improving the strength of the cover member, that is, by making the locked portion also have a function of reinforcing the cover member.

  The present invention has been made from such a viewpoint, and is a drug body container having a storage space for storing a drug body containing a drug and having shape retention, and a support member for supporting the drug body And a cover member that accommodates the drug body together with the support member, and the support member has a holding portion that holds a lower portion of the drug body, and a locking portion that can lock the cover member. The cover member has at least a cylindrical shape that opens downward, and has a cover body that forms the housing space together with the support member, and a locked portion that engages with the locking portion. The locking portion extends outwardly from a portion above the lower end of the outer peripheral surface of the cover body, extends downward from the outer end of the overhang portion, and extends in the circumferential direction of the cover body. Over the cover body A side wall portion having a shape that overlaps with the cover body for a direction, to provide a medicament material container having an engagement portion shaped to engage the connection has been provided the locking portion to the lower end of the side wall portion.

  In the drug body container, the locked portion of the cover member has the engaging portion that can be engaged with the locking portion of the support member, and has the protruding portion and the side wall portion, so that the cover member is reinforced. The rigidity of the cover member is ensured by the locked portion for engaging the cover member with the support member without providing a dedicated reinforcing portion. Specifically, the projecting portion has a shape projecting outward from the outer peripheral surface of the cover body, and the side wall portion extends downward from the outer end of the projecting portion and extends over the entire area in the circumferential direction. Since it has a shape that overlaps the cover main body in the radial direction, the section coefficient of the lower part of the cover member than the projecting part of the cover member is larger than that of the projecting part. Thereby, the intensity | strength of the site | part below the overhang | projection part is ensured among the said cover members. And the said engaging part is connected to the said side wall part, The engagement to the said supporting member of the said cover member is inhibited, without inhibiting the function which reinforces the said cover member by the said overhang | projection part and the said side wall part. Make it possible. In other words, the locked portion has the function of reinforcing the cover member in addition to the function of engaging with the locking portion of the support member. Both the engagement of the cover member to the support member and the reinforcement of the cover member can be performed while omitting the provision of a space for providing a dedicated reinforcing portion for reinforcing the cover member. Therefore, the bending deformation of the cover member due to the force for gripping the cover member when removing the cover member from the support member, that is, the force acting inward on the cover member is suppressed. Therefore, it is suppressed that a chemical | medical solution is squeezed out from a chemical | medical body when removing a cover member from a supporting member.

  Specifically, the engaging portion has a shape protruding inward from a lower end of the side wall portion, and the engaging portion engages with the outer peripheral surface of the cover body from the outer peripheral surface of the holding portion. A locking portion main body extending between the first portion and the engagement portion, and extending from the engagement portion to the engagement portion from above the engagement portion. It is preferable to have a protruding portion that protrudes outward from the side surface.

  In this way, a structure that restricts the displacement of the cover member in the direction away from the support member while avoiding the enlargement of the drug container in the radial direction is constructed. Specifically, since both the locking portion main body and the protruding portion are accommodated inside the side wall portion in the radial direction, and the protruding portion engages with the engaging portion from above the engaging portion in this state, The displacement of the cover member in the direction away from the support member is restricted while avoiding an increase in the radial dimension of the drug body container.

  In this case, the locking part main body and the side wall part are cylindrical, and the engaging part is separated from the protruding part in the circumferential direction of the side wall part and the upper surface of the engaging part. Is engaged with the projecting portion by displacing the engaging portion in the engaging direction approaching the projecting portion along the circumferential direction from the released state positioned below the upper surface of the projecting portion. It is preferable to have a shape in pressure contact with the lower surface of the protrusion in the combined state.

  According to this configuration, the engaging portion and the projecting portion are engaged with each other only by rotating the cover member relative to the support member in the engaging direction from the released state. Thus, since the engaging portion is in pressure contact with the lower surface of the protruding portion, the engaged state of both is stabilized.

  Further, in this case, the upper end of the holding portion bites into the cover member over the entire circumferential direction so as to seal the housing space when the locking portion and the locked portion are engaged with each other, or It is preferable that the lower end of the cover main body has a shape that bites into the support member over the entire circumferential direction.

  If it does in this way, the storage space enclosed by a support member and a cover main body will be sealed by engaging the said latching | locking part and the said to-be-latched part mutually.

  Specifically, it is preferable that the upper end of the holding portion has a shape that bites into the lower end of the cover body over the entire circumferential direction when the locking portion and the locked portion are engaged with each other.

  If it does in this way, the said storage space will be sealed by the said holding | maintenance part and the said cover main body. In other words, a sealed structure of the housing space is constructed inside the locking part and the locked part. Therefore, even when an external force acts on the locking portion or the locked portion and the like are deformed, the sealed state of the accommodation space is maintained.

  In this case, the locked portion further includes an extension wall portion extending downward from the lower end of the side wall portion, and the position of the lower end of the extension wall portion is lower than the position of the lower end of the cover body. It is preferable that they are set as follows.

  If it does in this way, the site | part below the said overhang | projection part among the said cover main bodies will overlap the said side wall part and the said extension wall part in the said radial direction over the whole area of an up-down direction. Therefore, the intensity | strength of the site | part below the said overhang | projection part among the said cover members improves further. Furthermore, even when this cover member is placed on a table or the like having a flat surface, the lower end of the extension wall portion comes into contact with the surface of the table, so that the table at the lower end of the cover body. Since contact with the surface of the cover is avoided, damage to the lower end of the cover body is avoided. Therefore, the biting of the upper end of the holding portion into the lower end of the cover body at the time of engagement between the locking portion and the locked portion is kept good.

  In the present invention, the locked portion further includes a riding portion that rides on the protruding portion, and the engaging portion is moved in the circumferential direction so that the riding portion is changed from the engaged state to the released state. The cover main body has a shape that rides on the protruding portion so as to gradually move away from the support member in the axial direction as it is displaced in the release direction as it is after being displaced in the release direction opposite to the engagement direction. preferable.

  In this case, the cover body is separated from the support member in the axial direction after the cover member is turned into the release state by rotating the cover member relative to the support member in the release direction. Removal from the support member is facilitated.

  In this case, the locked portion further includes a pair of convex portions projecting downward from both ends in the circumferential direction of the engaging portion, and a lower end of the pair of convex portions is a lower end of the riding portion. The circumferential dimension of the projecting portion is the lower end of the raised portion, the lower end of the adjacent convex portion adjacent in the circumferential direction, and the lower end of the raised portion, of the pair of convex portions. And the dimension between the lower ends of each of the pair of convex portions is preferably set.

  According to this configuration, when the cover member is rotated relative to the support member in the release direction, the cover main body is separated from the support member in the axial direction. It is maintained until it is separated in the circumferential direction from the convex portion located on the opposite side of the riding portion with respect to the adjacent convex portion. Therefore, it becomes easier to remove the cover member.

  As described above, according to the present invention, it is possible to provide a drug body container capable of suppressing deformation of the cover member when the cover member is removed.

It is a perspective view of the chemical body container of one embodiment of the present invention. It is a perspective view of the support member of the chemical | medical agent container shown in FIG. It is sectional drawing which shows the state with which the supporting member shown in FIG. 2 was piled up by the axial direction. It is the perspective view of the state which looked at the cover member of the chemical | medical agent container shown in FIG. 1 from upper direction. It is the perspective view of the state which looked at the cover member of the chemical | medical agent container shown in FIG. 1 from the downward direction. It is sectional drawing which shows the state with which the cover member shown in FIG. 4 was piled up by the axial direction. It is sectional drawing of the chemical | medical agent container shown in FIG. It is an enlarged view which shows the vicinity of a latching | locking part and a to-be-latched part. (A) It is a figure which shows the engagement state which the latching | locking part and the to-be-latched part mutually engaged. (B) It is a figure which shows the cancellation | release state in which engagement with the latching | locking part and the to-be-latched part was cancelled | released. (C) It is a figure which shows the state immediately after riding on a protrusion part. (D) It is a figure which shows the state in which a pair of convex part is located in the upper surface of a protrusion part. (E) It is a figure which shows the state immediately after a pair of convex part passed the protrusion part. It is sectional drawing which shows the modification of a latching | locking part and a to-be-latched part.

  A drug body container according to an embodiment of the present invention will be described with reference to FIGS. In the following description, the vertical and horizontal directions are based on FIG. The drug body container has a storage space for storing a drug body 10 (see FIG. 7) having shape retention. The drug body 10 accommodated in the accommodation space contains chemicals such as a fragrance, a deodorant, and a deodorant. In the present embodiment, the drug body 10 is in a gel form.

  As shown in FIGS. 1 and 7, the drug body container of the present embodiment includes a support member 20 that supports the drug body 10 and a cover member 40 that houses the drug body 10 together with the support member 20. .

  As shown in FIG. 2, the support member 20 includes a holding portion 22, a cylindrical portion 26, a regulating piece 28, and a locking portion 30 that can lock the cover member 40.

  The holding unit 22 holds the lower part of the drug body 10. Specifically, the holding part 22 has a cylindrical gripping part 23 and a bottom wall 24.

  The grip part 23 has a shape that surrounds the lower part of the drug body 10 from its periphery. A knurl is formed on the outer peripheral surface of the grip portion 23. As shown in FIG. 8, the upper end 23 a of the grip portion 23 is formed in a shape that bites into the cover member 40 in a state where the locking portion 30 locks the cover member 40. The bottom wall 24 is connected to the lower end of the gripping portion 23 and has a shape that closes the lower opening of the gripping portion 23 except for the central opening formed at the center thereof.

  The cylindrical portion 26 has a shape that protrudes upward from the peripheral edge portion of the central opening of the bottom wall 24. As shown in FIGS. 3 and 7, a step portion 26 a is formed on the inner peripheral surface of the cylindrical portion 26. In this embodiment, when the cylindrical portion 26 of the specific support member 20 is inserted into the cylindrical portion 26 of the specific support member 20, the cylindrical portion 26 of the specific support member 20 is inserted. The shape of the step portion 26a is set so that the upper end 26b of the cylindrical portion 26 of the another support member 20 contacts the step portion 26a. That is, a plurality of support members 20 can be stacked in the axial direction.

  The regulating piece 28 has a shape that regulates the relative rotation of the drug body 10 with respect to the holding part 22 and the cylindrical part 26 by biting into the lower part of the drug body 10. The restriction piece 28 is connected to the upper surface of the bottom wall 24 and the outer peripheral surface of the lower end portion of the cylindrical portion 26.

  The locking portion 30 is connected to the outer peripheral surface of the upper portion of the grip portion 23 and has a shape that can be engaged with the cover member 40. Specifically, the locking portion 30 includes a locking portion main body 32 and a protruding portion 34.

  The locking portion main body 32 has a shape extending upward from the outer peripheral surface of the upper portion of the grip portion 23. The locking portion main body 32 has a cylindrical shape connected over the entire circumferential direction of the grip portion 23.

  The protruding portion 34 has a shape that protrudes outward from the outer peripheral surface of the locking portion main body 32. The protrusion 34 has a shape extending along the circumferential direction. As shown in FIGS. 2 and 9, the lower surface 34b of the protrusion 34 is orthogonal to the axial direction (vertical direction in FIG. 9) so as to gradually go downward as it goes from one end to the other end in the circumferential direction. Inclined with respect to the plane. In the present embodiment, the protruding portions 34 are connected to six locations arranged at equal intervals along the circumferential direction of the outer peripheral surface of the locking portion main body 32.

  The cover member 40 includes a cover body 42 that forms the housing space together with the support member 20, and a locked portion 50 that can be engaged with the locking portion 30 of the support member 20.

  The cover main body 42 includes a cylindrical body 44 and a closing portion 46. 4 and 5, the illustration of the blocking portion 46 is omitted.

  The cylindrical body 44 has a cylindrical shape that opens in the vertical direction, and a cross section in a direction (horizontal direction in FIG. 7) orthogonal to the axial direction (vertical direction in FIG. 7) is circular throughout the axial direction. The upper end 23a of the gripping portion 23 bites into the lower end 44a of the cylindrical body 44 over the entire circumferential direction when the locking portion 30 and the locked portion 50 are engaged with each other. A step 44 b is formed on the outer peripheral surface of the cylindrical body 44. In the present embodiment, as shown in FIG. 6, when the cylinder 44 of the cover member 40 different from the specific cover member 40 is inserted into the cylinder 44 of the specific cover member 40, the specific The shape of the step 44b is set so that the inner peripheral surface of the cover member 40 in the vicinity of the lower end of the tube 44 abuts on the step 44b of the tube 44 of the other cover member 40. That is, a plurality of cover members 40 can be stacked in the axial direction.

  As shown in FIG. 7, the closing portion 46 has an annular shape that closes an annular opening formed between the inner peripheral surface surrounding the upper opening of the cylindrical body 44 and the outer peripheral surface of the upper end of the cylindrical portion 26. A top plate 46a, a first claw portion 46b connected to the lower surface of the top plate 46a and engaged with the upper end of the cylindrical body 44, and a top plate 46a connected to the lower surface of the top plate 46a and engaged with the upper end of the cylindrical portion 26 A second claw portion 46c.

  The locked part 50 includes an overhang part 52, a side wall part 54, an engagement part 56, an extension wall part 58, a riding upper part 60, and a pair of convex parts 62.

  The projecting portion 52 has a shape projecting from the portion above the lower end of the outer peripheral surface of the cylindrical body 44 toward the radially outer side. In the present embodiment, the overhanging portion 52 is formed with a through hole 52a that penetrates the overhanging portion 52 in the thickness direction (vertical direction in FIG. 7). The through holes 52 a are formed at six locations arranged at equal intervals along the circumferential direction of the overhang portion 52.

  The side wall portion 54 has a shape extending downward from the outer end of the overhang portion 52. The side wall portion 54 has a cylindrical shape connected over the entire region in the circumferential direction. The side wall portion 54 overlaps the cylindrical body 44 in the radial direction.

  The engaging part 56 has a shape protruding inward from the lower end of the side wall part 54. The upper surface 56a of the engaging portion 56 is a flat surface parallel to a plane orthogonal to the axial direction. The engaging portion 56 engages with the protruding portion 34 in a state where the engaging portion 56 overlaps the protruding portion 34 in the vertical direction so as to be positioned below the protruding portion 34. Specifically, the engaging portion 56 is in a released state in which the engaging portion 56 is separated from the protruding portion 34 in the circumferential direction and the upper surface 56a of the engaging portion 56 is positioned below the upper surface 34a of the protruding portion 34. Then, the engaging portion 56 is displaced in the engaging direction approaching the protruding portion 34 along the circumferential direction, so that the engaging portion 56 is engaged with the protruding portion 34 while being positioned below the protruding portion 34. In this engaged state, the engaging portion 56 is in pressure contact with the lower surface 34 b of the protruding portion 34. On the other hand, from the engaged state until the engaging portion 56 does not overlap the protruding portion 34 in the vertical direction (until the engaging portion 56 is separated from the protruding portion 34 in the circumferential direction), the engaging portion 56 is The release state is achieved by displacing the direction in the release direction opposite to the engagement direction (the direction of the arrow formed on the outer peripheral surface of the cylindrical body 44 in FIGS. 1 and 4). In the present embodiment, the engaging portion 56 is provided at a position overlapping with the through hole 52a of the overhanging portion 52 in the vertical direction, and is set in a shape that fits in the through hole 52a in a top view.

  The extension wall portion 58 has a shape extending downward from the lower end of the side wall portion 54. As shown in FIG. 8, the position of the lower end 58 a of the extension wall portion 58 is set to be lower than the position of the lower end 44 a of the cylindrical body 44.

  The riding portion 60 has a shape that rides on the protruding portion 34 when the engaging portion 56 is displaced in the release direction. Specifically, the riding portion 60 has a sliding surface 60a that slides with respect to the protruding portion 34 when the engaging portion 56 is displaced in the releasing direction. As shown in FIGS. 9A to 9C, the sliding surface 60a is changed from the engaged state (the state of FIG. 9A) to the released state (the state of FIG. 9B). Thus, after the engaging portion 56 is displaced in the releasing direction, the engaging portion 56 is displaced in the releasing direction as it is, so that the riding upper portion 60 rides on the protruding portion 34. In the present embodiment, the sliding surface 60a has a shape that is linearly inclined so as to gradually go downward as it goes in the engagement direction (left direction in FIG. 9). The cover body 42 is gradually separated from the support member 20 in the axial direction from the time when the sliding surface 60a of the riding portion 60 contacts the protruding portion 34 until the lower end of the riding portion 60 rides on the upper surface 34a of the protruding portion 34. To do. In the present embodiment, the riding portion 60 is connected to the lower surface of the overhang portion 52 and the inner side surfaces of the side wall portion 54 and the extension wall portion 58.

  The pair of convex portions 62 has a shape that protrudes downward from both ends of the engaging portion 56 in the circumferential direction. The lower ends of the pair of convex portions 62 are set at the same height position as the lower end of the riding portion 60. In the present embodiment, as shown in FIGS. 9D to 9E, the circumferential dimension of the protruding portion 34 is adjacent to the riding upper portion 60 of the pair of convex portions 62 in the circumferential direction. It is set to be larger than the dimension L1 between the lower end of the adjacent convex part 62a and the lower end of the riding part 60 and the dimension L2 between the respective lower ends of the pair of convex parts 62. The pair of convex portions 62 are connected to the inner side surface of the extension wall portion 58.

  In the present embodiment, the cover member 40 has reinforcing ribs 64 for reinforcing the cover member 40. The reinforcing rib 64 is connected to the upper surface of the overhang portion 52 and the outer peripheral surface of the cylindrical body 44.

  Here, the process of supplying the drug body 10 into the drug body container of the present embodiment will be described.

  First, the closing portion 46 is removed from the cylindrical body 44. Then, a part of the cover member 40 other than the blocking part 46 is assembled to the support member 20. Specifically, the cylindrical body 44 is relatively rotated in the engagement direction with respect to the support member 20 from the released state. Then, the upper surface 56a of the engaging portion 56 is pressed against the lower surface 34b of the protruding portion 34, so that the engaging portion 56 and the protruding portion 34 are engaged with each other. Thus, in the present embodiment, the protrusion 34 and the engagement portion 56 are engaged with each other only by rotating the cover member 40 relative to the support member 20 in the engagement direction from the released state. Since the upper surface 56a of the engaging portion 56 is in pressure contact with the lower surface 34b of the protruding portion 34 in the engaged state, the engaged state of both is stabilized. At this time, that is, when the engaged state is established, the upper end 23 a of the grip portion 23 bites into the lower end 44 a of the cylindrical body 44.

  Next, the inner peripheral surface of the cylindrical body 44 and the outer peripheral surface of the cylindrical portion 26 are formed from an annular opening formed between the inner peripheral surface surrounding the upper opening of the cylindrical body 44 and the outer peripheral surface of the upper end of the cylindrical portion 26. A medicine body forming material having fluidity is filled in the storage space between the two. The drug body shape material becomes the drug body 10 by solidifying. Then, the closing portion 46 is attached to the upper end of the cylindrical body 44. Thereby, the accommodation space is sealed. Specifically, when the locking portion 30 and the locked portion 50 are engaged with each other, the upper end 23a of the gripping portion 23 bites into the lower end 44a of the cylindrical body 44 over the entire circumferential direction. The housing space is sealed by attaching the closing portion 46 to the upper end of the body 44. Moreover, in the present embodiment, since the sealed structure of the accommodation space is constructed inside the locking portion 30 and the locked portion 50, an external force acts on the locking portion 30 or the locked portion 50, etc. Even when these are deformed, the sealed state of the accommodation space is maintained.

  Thereafter, the drug body forming material is solidified to form a drug body 10 having shape retention. In this way, the drug body 10 is supplied into the drug body container.

  Subsequently, a process of exposing the drug body 10 in the drug body container to the outside will be described.

  The cover member 40 is rotated relative to the support member 20 in the release direction. As a result, as shown in FIG. 9B, the engagement between the projecting portion 34 and the engaging portion 56 is released and a released state is established. Here, since the lower end portion of the cover main body 42 is a free end and the strength is relatively low in the cover main body 42, the force for gripping the cover member 40 when the cover member 40 is removed from the support member 20, That is, there is a concern that the cover main body 42 is bent and deformed due to the force acting inward on the cover member 40. However, in the drug body container of the present embodiment, the locked portion 50 of the cover member 40 has the engaging portion 56 that can be engaged with the locking portion 30 of the support member 20, and the overhang portion 52 and the side wall portion 54. Therefore, the rigidity of the cover member 40 is ensured by the locked portion 50 for engaging the cover member 40 with the support member 20 without separately providing a dedicated reinforcing portion for reinforcing the cover member 40. Yes. Specifically, the projecting portion 52 has a shape projecting outward from the outer peripheral surface of the cover main body 42, and the side wall portion 54 extends downward from the outer end of the projecting portion 52 and extends in the entire circumferential direction. The cover member 40 has a shape that overlaps with the cover main body 42 in the radial direction, so that the section modulus of the lower part of the cover member 40 is lower than that of the projecting part 52. Thus, the strength of the portion of the cover member 40 below the overhanging portion 52 is ensured. The engaging portion 56 is connected to the side wall portion 54, and the engagement of the cover member 40 to the support member 20 without hindering the function of reinforcing the cover member 40 by the overhang portion 52 and the side wall portion 54. Is possible. In other words, the locked portion 50 has the function of reinforcing the cover member 40 in addition to the function of engaging with the locking portion 30 of the support member 20. By providing in 42, both the engagement of the cover member 40 to the support member 20 and the reinforcement of the cover member 40 can be achieved while omitting a space for providing a dedicated reinforcing portion for reinforcing the cover member 40. It becomes possible. Therefore, bending deformation of the cover member 40 when the cover member 40 is removed from the support member 20 is suppressed. Accordingly, at this time, the squeezing out of the drug solution from the drug body 10 is suppressed.

  Then, after the engagement between the projecting portion 34 and the engaging portion 56 is released to be in the released state, the cover member 40 is continuously rotated in the releasing direction as shown in FIG. 9C. The riding upper part 60 rides on the protruding part 34. As a result, the cover main body 42 is separated from the support member 20 in the axial direction. Therefore, the cover member 40 can be easily detached from the support member 20.

  Thereafter, by removing the cover member 40 from the support member 20, a portion of the drug body 10 covered with the cover body 42 is exposed. Here, as shown in FIGS. 9D and 9E, the circumferential dimension of the protrusion 34 is set to be larger than the dimension L1 and the dimension L2. Is maintained from the support member 20 in the axial direction until the protruding portion 34 is separated from the convex portion 62 different from the adjacent convex portion 62a in the pair of convex portions 62 in the circumferential direction. Therefore, the removal of the cover member 40 is further facilitated.

  Even if water separation has occurred on the surface of the drug body 10, after removing the cover member 40 from the support member 20, the water separation is performed on the upper surface of the grip portion 23, the inner peripheral surface of the locking portion main body 32, and the drug. It is accommodated in a space surrounded by the outer peripheral surface of the body 10.

  As described above, in the drug body container of the present embodiment, the locked portion 50 has both the function of engaging with the locking portion 30 of the support member 20 and the function of reinforcing the cover member 40. The engagement of the cover member 40 to the support member 20 while omitting the provision of a space for providing a dedicated reinforcing portion for reinforcing the cover member 40 by providing the locked portion 50 in the cover main body 42. Both the reinforcement of the cover member 40 is possible.

  In the present embodiment, both the locking portion main body 32 and the protruding portion 34 are accommodated inside the side wall portion 54 and the extension wall portion 58 in the radial direction, and in this state, the protruding portion 34 extends from above the engaging portion 56. Since it engages with the engaging portion 56, displacement of the cover member 40 in the direction away from the support member 20 is restricted while avoiding an increase in the radial dimension of the drug body container.

  Further, in the present embodiment, the locked portion 50 has the extension wall portion 58, and the position of the lower end 58 a of the extension wall portion 58 is set to be lower than the position of the lower end 44 a of the cylindrical body 44. Therefore, a portion of the cover main body 42 that is lower than the overhanging portion 52 overlaps with the side wall portion 54 and the extension wall portion 58 in the radial direction over the entire vertical direction. Therefore, the strength of the portion of the cover member 40 below the overhanging portion 52 is further improved. Furthermore, even when the cover member 40 is placed on a table or the like having a flat surface, the lower end 58a of the extension 44 is brought into contact with the surface of the table 44 so that the lower end 44a of the cylindrical body 44 is contacted. Is prevented from contacting the lower surface 44a of the cylindrical body 44. Therefore, the biting of the upper end 23a of the gripping part 23 into the lower end 44a of the cylindrical body 44 during engagement of the locking part 30 and the locked part 50 is kept good.

  Moreover, in this embodiment, the engaging part 56 is provided in the position which overlaps with the through-hole 52a formed in the overhang | projection part 52 in the up-down direction, and since it has a shape which fits in the through-hole 52a in top view. The mold used when molding the cover member 40 is simplified. Specifically, the cover member 40 is easily formed by using an upper and lower mold that can be divided into upper and lower portions with the engaging portion 56 as a boundary.

  Moreover, in this embodiment, since the support member 20 can be piled up in an axial direction, it becomes possible to store and transport the plurality of support members 20 in a space-saving manner. Moreover, the damage of each support member 20 is suppressed by storing and transporting the plurality of support members 20 in a state of being overlapped with each other. The same applies to the cover member 40.

  In addition, it should be thought that the said embodiment disclosed this time is an illustration and restrictive at no points. The scope of the present invention is shown not by the above description of the embodiments but by the scope of claims for patent, and further includes all modifications within the meaning and scope equivalent to the scope of claims for patent.

  For example, in the above embodiment, the engaging portion 56 has a shape that protrudes inward from the lower end of the side wall portion 54, and both the locking portion main body 32 and the protruding portion 34 of the locking portion 30 are cylindrical in the radial direction. Although the example which has the shape which fits between the outer peripheral surface of 44, the side wall part 54, and the extension wall part 58 was shown, the section modulus of the site | part below the overhang | projection part 52 among the cover members 40 has the overhang part. If it becomes larger than that of the site | part above 52, the shape of the latching | locking part 30 and the to-be-latched part 50 is not restricted to this. For example, as shown in FIG. 10, the engaging portion 56 may protrude outward from the lower end of the side wall portion 54. In this case, the locking portion main body 32 of the locking portion 30 includes a first main body portion 32a that protrudes outward from the outer peripheral surface of the gripping portion 23 to the outside of the engaging portion 56, and the first main body portion. And a second main body portion 32b extending upward from the outer end of 32a to above the engaging portion 56, and the protruding portion 34 extends from above the engaging portion 56 to the engaging portion 56. It is preferable to have a shape that protrudes inward from the inner surface of the second body portion 32b so as to engage.

  Moreover, in the said embodiment, although the example which both fit by the relative rotation of the cylinder 44 with respect to the supporting member 20 in the said engagement direction was shown, both fitting methods are not restricted to this. . For example, the engaging portion 56 protrudes from a state in which the protruding portion 34 and the engaging portion 56 overlap each other so that the engaging portion 56 of the cover member 40 is positioned above the protruding portion 34 of the support member 20. The support member 20 and the cover member 40 may be fitted to each other by pressing the cover member 40 downward so that the two members overlap with each other while vertically overlapping each other.

  Moreover, in the said embodiment, the lower surface 34b of the protrusion part 34 is a shape which inclines with respect to the plane orthogonal to the said axial direction, and the upper surface 56a of the engaging part 56 is a flat surface parallel to the plane orthogonal to the said axial direction. However, the shapes of these surfaces may be reversed. That is, the lower surface 34b of the protruding portion 34 is a flat surface parallel to a plane orthogonal to the axial direction, and the upper surface 56a of the engaging portion 56 is directed upward as it is separated from the protruding portion 34 in the circumferential direction. The shape may be inclined with respect to a plane orthogonal to the axial direction.

  Further, the lower end 44a of the cylindrical body 44 may have a shape that bites into the upper end 23a of the gripping portion 23 or the inner side surface of the locking portion main body 32 when the locking portion 30 and the locked portion 50 are engaged with each other. Good.

  Moreover, the drug substance container of this embodiment may be used as a container for refilling. That is, the drug body container may be mounted in a cosmetic cover container having a shape covering the outside of the drug body container. In this case, the cover body 40 with the cover member 40 removed from the drug body container in which the drug body 10 is housed is mounted in the cover container. In this way, exposure of the drug body 10 to the outside is avoided.

DESCRIPTION OF SYMBOLS 10 Drug body 20 Support member 22 Holding | maintenance part 23 Holding part 23a Upper end of a holding part 30 Locking part 32 Locking part main body 34 Projection part 34a Upper surface of projection part 34b Lower surface of projection part 40 Cover member 42 Cover body 44 Cylinder body 44a Cylinder Lower end of body 46 Closed portion 50 Locked portion 52 Overhang portion 52a Through hole 54 Side wall portion 56 Engagement portion 56a Upper surface of engagement portion 58 Extension wall portion 60 Riding portion 60a Sliding surface 62 Pair of convex portions 64 Reinforcing ribs

Claims (8)

A drug body container having a storage space for containing a drug body containing a drug and having shape retention,
A support member for supporting the drug body;
A cover member that houses the drug body together with the support member,
The support member includes a holding portion that holds a lower portion of the drug body, and a locking portion that can lock the cover member
The cover member has a cylindrical body that opens at least downward and has a cover body that forms the housing space together with the support member, and a locked portion that engages with the locking portion,
The locked portion extends outward from a portion above the lower end of the outer peripheral surface of the cover main body, and extends downward from the outer end of the extended portion, and also extends in the circumferential direction of the cover main body. A drug body container having a side wall portion shaped to overlap the cover main body in the radial direction of the cover main body, and an engaging portion connected to the lower end of the side wall portion and engaged with the locking portion. . The drug body container according to claim 1,
The engaging portion has a shape protruding inward from the lower end of the side wall portion,
The locking portion includes a locking portion main body having a shape extending from the outer peripheral surface of the holding portion through the outer peripheral surface of the cover body and the engaging portion to reach the upper portion of the engaging portion; A drug body container having a protruding portion that protrudes outward from an outer surface of the locking portion main body so as to engage with the engaging portion from above the engaging portion. The drug body container according to claim 2,
The locking part main body and the side wall part are cylindrical,
The engaging portion moves from the released state in which the engaging portion is separated from the protruding portion in the circumferential direction of the side wall portion and the upper surface of the engaging portion is positioned below the upper surface of the protruding portion in the circumferential direction. A pharmaceutical body container having a shape that engages with the projecting portion by being displaced in an engaging direction in which the engaging portion approaches the projecting portion and press-contacts the lower surface of the projecting portion in this engaged state. The drug body container according to claim 3,
The upper end of the holding portion bites into the cover member over the entire area in the circumferential direction so as to seal the housing space when the locking portion and the locked portion are engaged with each other, or A drug body container having a shape in which a lower end bites into the support member over the entire circumferential direction. The drug body container according to claim 4,
A drug body container having a shape in which an upper end of the holding portion bites into a lower end of the cover body over the entire circumferential direction when the locking portion and the locked portion are engaged with each other. The drug body container according to claim 5,
The locked portion further includes an extension wall portion extending downward from the lower end of the side wall portion, and the position of the lower end of the extension wall portion is set to be lower than the position of the lower end of the cover body. Drug body container. The drug body container according to any one of claims 3 to 6,
The locked portion further includes a riding portion that rides on the protruding portion, and the engaging portion has the engagement direction in the circumferential direction so that the engagement portion is changed from the engaged state to the released state. A drug body container having a shape that rides on the protruding portion so that the cover body is gradually separated from the support member in the axial direction as it is displaced in the release direction after being displaced in the opposite release direction. The drug body container according to claim 7,
The locked portion further includes a pair of convex portions protruding downward from both ends in the circumferential direction of the engaging portion, and the lower ends of the pair of convex portions are the same height as the lower end of the riding portion. Set to position,
The dimension of the protrusion in the circumferential direction is the dimension between the lower end of the raised portion and the lower end of the raised portion adjacent to the upper portion of the pair of convex portions and the circumferential direction, and the pair of convex portions. A drug body container that is set to be larger than the dimension between the respective lower ends thereof.

Images